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Background: Vasa praevia (VP) is an obstetric condition that is associated with significant perinatal mortality and
morbidity. Although the incidence of VP is low, it is one of the few causes of perinatal death that can be potentially
prevented through detection and appropriate care. The experience of women diagnosed with or suspected to have VP
is largely unknown. The aim of this study was to explore the experiences and impact that a diagnosis or suspected
diagnosis of VP had on a group of Australian women.
Method: A qualitative study using a descriptive exploratory design was conducted and Australian women diagnosed
with VP were recruited via online methods in 2012. An inductive approach was undertaken and interviews were
analysed using the stages of thematic analysis.
Results: Of the 14 women interviewed, 11 were diagnosed with VP during pregnancy with 5 subsequently found not
to have VP (non-confirmed diagnosis). Three women were diagnosed during childbirth with one neonatal death. Five
major themes were identified: feeling like a ticking time bomb; getting diagnosis right; being taken seriously; coping
with inconsistent information; and, just a massive relief when it was all over.
Conclusions: This is the first study to describe women’s experience of being diagnosed with or suspected to have VP.
The findings from this research reveal the dilemmas these women face even if their baby is ultimately born healthy.
Their need for clear and consistent information, sensitive care, support and continuity is evident. Clinicians can use
these findings in developing information, counselling and models of care for these women.
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Vasa praevia (VP) is a condition that carries a high risk of
death of an otherwise normal baby. The reported perinatal
mortality when the condition is not diagnosed and appro-
priately managed is approximately 60% [1,2]. VP occurs
when exposed fetal blood vessels, unsupported by the
placenta or the umbilical cord, run over the cervix [3].
The exposed fetal vessels are in danger of rupture in late
pregnancy or in labour, carrying a high risk of death of the
baby. Although the incidence of VP has been estimated to
be 1 in 2500 births [3], it is potentially under reported
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unless otherwise stated.to be 1 in 202- 293 births [6,7]. Although VP is rare, it is a
significant pregnancy complication [8,9]. The risk factors
for VP include placenta praevia, low lying placenta [10],
multiple pregnancies [11,12], in-vitro-fertilisation (IVF)
[6,7], bilobed or succenturiate lobed placenta and vela-
mentous insertion of the cord. In recent years, it has be-
come possible to diagnose VP during pregnancy using
ultrasound [11,13-16] with definitive diagnosis being made
in the third trimester once the lower segment is formed.
Women diagnosed at risk for VP during the second tri-
mester need to be confirmed in the third trimester [17] as
in some women VP may resolve spontaneously as preg-
nancy progresses due to an increase in the distance of the
fetal vessels from the internal os as the uterus expands.
However, there is little international consensus in defining
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lower segment formation, or during labour on visualisa-
tion of the fetal vessels in the membranes or on examin-
ation of the placenta after birth.
Making the diagnosis and delivering the baby by caesar-
ean section (CS) prior to the onset of labour will prevent
the death of the baby in the majority of cases [2,18]. Des-
pite evidence that VP carries a high perinatal mortality,
can be diagnosed prenatally, and that perinatal death can
be avoided in most cases by accurate diagnosis and appro-
priate management, there remains a lack of consensus
among medical professionals regarding screening for VP,
and on the optimal management of women who are diag-
nosed with the condition. A number of studies have de-
scribed approaches to the management of women with VP
including hospitalisation at 30-32 weeks and elective CS
at 34-35 weeks of gestation [17,19]. However, there are
few national guidelines to support these practices. The So-
ciety of Obstetricians and Gynaecologists of Canada
(SOGC) developed guidelines in 2009 [20]. The Royal Col-
lege of Obstetricians and Gynaecologists (RCOG) in the
UK updated their “Green Top Guideline 27” for placenta
praevia to include guidance about diagnosis and manage-
ment of VP in 2011 [21]. Currently, there are no national
guidelines in Australia although the Royal Australian and
New Zealand College of Obstetricians and Gynaecologists
(RANZCOG) released a College Statement in 2012, which
recommended hospitalisation and elective CS for women
diagnosed with VP, but reported ‘no agreed protocols for
timing of admission to hospital or timing of elective caesar-
ean section’ [22].
Given the perinatal risks, challenges in the diagnosis of
VP and the lack of consensus of optimal management
among medical professionals, there is a potential for a
diagnosis of VP to lead to significant anxiety and uncer-
tainty among women and has considerable impact on
their pregnancies and birth plans, with the potential dis-
ruption of their personal lives and those of their families.
Despite this, the experience of women diagnosed with or
at risk of VP is largely unknown and has not, to our
knowledge, been described. The aim of this study was to
explore the experiences and impact that a diagnosis or
suspected diagnosis of VP had on a group of Australian
women.
Methods
A qualitative study using a descriptive exploratory design
was undertaken [23]. Qualitative descriptive studies are
particularly useful when seeking to describe people's re-
sponses to an event. The method is ideal for research
that focuses on the ‘who, what, why, and where’ of
events and is useful when investigating previously un-
examined experiences. The aim of descriptive explora-
tory studies is generally to present a comprehensivesummary of events as experienced by the participants in
the event [23,24].
Human research ethical approval was received from
the University of New South Wales Human Research
Ethics Committee prior to commencement.
Setting and participants
Women were recruited during 2012 through the Inter-
national Vasa Previa Foundation (IVPF). The IVPF is a
not-for-profit organisation providing information and sup-
port about VP and education for consumers and clini-
cians. A notice was put on the Facebook page of the IVPF
and an email was sent to members of the closed ‘Vasa
praevia Yahoo Group’ in July 2012; asking interested
women who were diagnosed with this condition and had
their care in Australia to contact a researcher.
To be eligible, a woman had to have been diagnosed
with VP during pregnancy or childbirth while living in
Australia, speak English and be willing and able to pro-
vide consent.
Data collection
Data were collected using one-to-one interviews which
were conducted by telephone. Prior to the interview,
women were sent study information leaflets and asked
to provide written consent to participate. Interviews
were audio-recorded. The interviews took between 30-
90 minutes with a mean of 50 minutes and were guided
by a series of semi-structured open-ended questions.
One author, LH, an experienced qualitative researcher,
undertook all the interviews. Fifteen women volunteered
for the study and were interviewed. One woman was ex-
cluded from the analysis as she had her diagnosis of VP
and pregnancy care in another country. A total of 14
women were included in the analysis.
Trigger questions used in the interviews
Can you talk about your experience?
How were you diagnosed?
How did you and your partner react to the news?
What was it like to receive a diagnosis?
How were you cared for and what did you think about
this care?
What did you previously know about vasa praevia?
Can you talk about your birth and your baby?
When you think back, is there anything that you think
was handled well and anything that should have been
done differently?
Data analysis
Interviews were transcribed verbatim. An inductive ap-
proach was taken and data was analysed using the stages of
thematic analysis [25]. Audio interviews were listened to
and transcripts were read through several times by two of
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transcripts. The researchers met on a regular basis to dis-
cuss the concepts and developed these into codes and
themes. Women’s words have been chosen to describe the
themes.
Verification of the final codes and themes was under-
taken by inviting a consumer who had experienced vasa
praevia and had many years of experience in talking with
women in this situation to read the analysis for content
and face validity.Findings
Women were aged from 27-38 years at the time of diag-
nosis, had a singleton pregnancies, and all were married
or in a long term relationship with a male partner. Eleven
women were diagnosed with VP during pregnancy with
five not confirmed to have VP on subsequent follow up
ultrasound. One woman who was diagnosed during preg-
nancy did not have confirmation of VP in late pregnancy;
however VP was confirmed at birth.Table 1 Pregnancy and diagnosis details of the women (n=14
Group Gestational age range risk of VP
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3. Diagnosed during birth CS G4P1
Vaginal bleeding and CS G1P0
Vaginal bleeding and CS G1P0
*Gestational age range is presented to protect women’s identity.
#Gravidity/parity at the pregnancy VP was diagnosed.
US: Ultrasound, G: Gravidity P: Parity, CS: Caesarean Section, IVF: In-vitro-fertilisationThree women were diagnosed at the time of childbirth.
One of these had an elective CS due to a previous CS; and
the other two had vaginal bleeding after an induction of
labour and had emergency CSs. In this latter group, there
was one neonatal death within 48 hours of birth and one
baby who had an Apgar score of 1, 3 and 5 at one, five
and ten minutes of birth, but was successfully resuscitated.
Table 1 provides details regarding the women’s pregnancy
characteristics including the gestation at diagnosis, pres-
ence of risk factors for VP and birth details. All except
two women had at least one risk factor for VP, as de-
scribed in the literature [3,4,7,8,10-12].
Six major themes were identified from the data. These
were: (1) Feeling like a ticking time bomb; (2) Getting the
diagnosis right; (3) Being taken seriously; (4) Coping with
inconsistent information; (5) Just a massive relief when it
was all over; and, (6) Making the experience better.
Quotes from women are identified in quotation marks
and italics to highlight the themes. Women are identi-
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at the time of the childbirth. For example, participant 1-4
represents group one, fourth interviewee.
Results
‘Feeling like a ticking time-bomb’
“After finding out, it was hard to be relaxed and you
felt like a ticking time-bomb – that you weren’t sure
what you could do” (participant 2-4)
‘Feeling like a ticking time-bomb’ expressed the fear,
anxiety, uncertainty and distress that women felt, par-
ticularly those diagnosed in pregnancy regardless of their
final diagnosis. Most women expressed fear when they
were diagnosed, describing it as ‘overwhelming and
scary’ and ‘worrying’. They frequently used words such
as ‘shocked’, ‘traumatised’ and a number were ‘unable to
think positively about the pregnancy or the baby’. One
woman said:
“I did nothing, went nowhere… I just stayed at home. I
didn't go back to work… I pretty much wrapped myself
in cotton wool and stayed at home”. (participant 1-4)
Fear of losing the baby further traumatised the preg-
nancy for most women. Some expressed that they could
not relax and enjoy their pregnancy, describing their ex-
perience as ‘just kind of life changing because you are so
close to death and living with that’. One woman reported:
“I became very cautious about any physical exertion;
didn’t ever go very far from home (lived 10 mins from
the hospital) and furthest I walked for the rest of my
pregnancy was 0.25-0.5 km up the road. I am usually
a very positive and optimistic person, but I found it
quite hard to be positive especially in the early weeks
after diagnosis”. (participant 2-1)
Another woman commented:
“I completely gave up exercise … I was constantly
thinking about the baby. My behaviour did change
after the diagnosis. I didn't want to do too much
strenuous exercise in case I ruptured something”.
(participant 1-6)
Some women could not connect with the baby and
were afraid of bonding as they felt they might lose the
baby, as this women expressed:
“I didn't feel excited about the pregnancy. I couldn't
pick a name. I didn't buy anything. I didn't set up a
room. I just didn't want to really do anything becauseI was frightened of the prospects that the baby
wouldn't make it”. (participant 1-1)
Stress was strongly expressed by almost all women di-
agnosed during pregnancy. One described the cumula-
tive impact of the stress as the pregnancy progressed,
saying:
“… there was constant stress and worry … this was
just building up to the worst possible day [the birth]. I
was just so terrified of losing the baby or having a
baby that had a brain injury”. (participant 1-1)
The three women who were diagnosed at the time of
birth also experienced shock and trauma, although this
occurred later than those diagnosed in pregnancy. One
woman, despite not experiencing fetal bleeding due to
having an elective CS, and giving birth to a healthy baby,
still relayed that she ‘spent so much time in shock’ and
was ‘horrified’, after the diagnoses was made. She felt she
came close to losing her baby and could not stop think-
ing about ‘what could have happened’.
‘Getting the diagnosis right’
“Vasa praevia is not an accident. It is not something
where you just roll the dice and take your chances
and it is something that can be diagnosed”.
(participant 3-1)
Many women, even those with a changed diagnosis,
were very grateful that the initial diagnosis of VP was
made. Statements like: ‘I felt lucky to have the antenatal
diagnosis’, and, ‘I was grateful to have the diagnosis and a
plan to stay in hospital’ expressed the relief at having a
diagnosis and a plan of care. One woman talked about
the sonographer who did the first diagnosis of VP and
‘thought he was quite a hero for finding it’. She went on
to say:
“I was pleased with the sonographer picking it up. We
thought it was amazing and impressed and we were
really glad and honoured to have him pick it up, the
initial diagnosis”. (participant 2-5)
In contrast, some women questioned the health system
for not picking up the VP during pregnancy. One
woman who was diagnosed during a CS and her baby
was born healthy, considered herself ‘lucky’, but said:
“It just really made me, not angry, but I just didn't
understand how it could be missed, like how it could
not be important to find out. I said to the obstetrician
that I want to know how this got missed. Why isn't this
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the umbilical cord and how they insert in to each
other and match up. You know, that's ridiculous. Espe-
cially when you are paying for extra hospital cover
and private health insurance and all that stuff and to
still have someone say well it is an economic decision
whether your baby gets a chance of being born alive or
not”. (participant 3-1)
Even when the diagnosis was made, there was incon-
sistency in the management. All but one woman had
follow-up ultrasounds to confirm the diagnosis at later
gestation. The exception explained:
“…at the 18 week scan that [VP] was confirmed. There
was some discussion that I might have a 28 week scan
but I didn't have that because my doctor was
confident that nothing would have changed or that
the management would be any different…”.
(participant 1-1)
Women were very keen for their caregivers to ‘get the
diagnosis right’. This was particularly challenging for the
five women whose diagnosis was changed. These women
felt ‘confused’ as they perceived a lack of confidence
within the clinicians. One woman felt ‘extraordinarily
upset’ about the changed diagnosis and did not trust that
it was not VP. She did not feel safe to have a natural
birth and questioned ‘the distance that makes it not vasa
praevia and when does it become velamentous cord in-
sertion’. She explained:
“I wanted him [first sonographer] to be involved again
and to double check and felt that there wasn't a
consensus absolutely with the doctors about it… they
didn't seem to kind of agree on the way in which it
[the distance of fetal vessels from internal os] was
being measured. So we opted for a caesarean and
continued to be monitored. I found those weeks almost
the most stressful”. (participant 2-5)
Similarly, another woman commented:
“The obstetrician said that it's not really vasa
praevia anymore and that I could go home if I
wanted. So we were really confused then. He couldn't
tell me, when we said “well what is a safe distance?”
he couldn't say. Well it's now 3 cm away …, again
there didn't seem to be anything to guide us on that
and no-one really wanted to commit to saying
anything.” (participant 2-2)
One woman who was diagnosed at 32 weeks and then
had the diagnosis changed at 36 weeks, felt ‘confused’ asshe perceived her obstetrician was not confident with
this saying:
“the baby was really far down. So it was hard to do
the ultrasound. … They [sonographers] saw that there
was something there, but they didn’t think it was vasa
praevia.” (participant 2-4)
She was advised to have another ultrasound at
38 weeks but chose to have an elective CS and VP was
confirmed at birth. She reflected on this experience:
“They said we can do another ultrasound in two weeks
[at 38 weeks] and if we still don't find anything we
think you should have a natural birth…. The
obstetrician obviously noticed that I was nervous
about it and so on but I don't feel like they gave me
enough support or information about it. He told me
that he knew what it was and he even lost a baby to it
once. So I was surprised that he didn't take it more
seriously than he did… I was quite disappointed with
the lack of information or advice” (participant 2-4)
‘Being taken seriously’
“They [my carers] were absolutely fantastic. It was
very uncertain, the last 20 weeks of pregnancy, but
they kept a good eye on me and I had scans to check
the location of the blood vessels …. So I did feel very
well cared for and felt like it was being taken very
seriously which was great”. (participant 1-6)
Some women felt they were ‘taken seriously’ and were
very happy with their care. One woman who received
enough information about VP and was given a plan, ‘felt
confident’ with her doctors. She expressed that she ‘had
good care and good management of the vasa praevia’,
had ‘a lovely birth’ and considered herself ‘very lucky’.
Another felt ‘incredibly fortunate, supported and
confident’ with her doctors. She reported that ‘people
were taking steps to ensure that my baby was born
safely’. Another woman who was hospitalized at 34 weeks
expressed her satisfaction with her admission and care
saying:
“They were really good at answering questions… They
delivered the baby safely and kept me safe and the
baby safe for the last few weeks… they were just
incredible” (participant 1-3)
However, many more felt that they were ‘not taken ser-
iously’ as they were dissatisfied with the way the diagno-
sis was disclosed or explained to them. One woman
perceived ‘just given the initial news, being delivered in
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rest of it’. She further explained her response saying:
“He sort of rattled off it meant and went on to say how
he had delivered quite a lot of dead babies with this
condition. That was really not what you need to hear.
It was probably just the way he explained it. He said
“if you were in the bush in Africa you wouldn't have a
live baby” kind of thing. I found it was a little bit
insensitive for him to say something like that. I think
he was just trying to make light of the situation but I
didn't find that all that helpful”. (participant 1-6)
Most women felt that they did not receive enough in-
formation and advice at the time of diagnosis from their
health care providers and did not understand the risks.
Statements like ‘I just wanted to know’, ‘I always feel bet-
ter about things, when I know all the ins and outs of it’
and ‘I wanted the facts’ expressed women’s need for in-
formation. For example:
“I didn't think he [the obstetrician] was treating it
seriously enough. He sort of said “see this as a hiccup,
don't see this as a catastrophe” which is great. But it
didn't really help when you don't quite understand
exactly what the problem is”. (participant 1-6)
Almost all the women had no prior knowledge of VP.
This ‘lack of prior knowledge made it confusing’ and most
knew no-one who had the condition before with one
woman being certain that ‘no one else has experienced
this before’. Women found it ‘hard to explain to others’
and one woman said that ‘none of my friends knew about
VP’. Even when women were given information, some
could not understand what they were told, for example:
“I think that my doctor probably takes for granted
some basic medical knowledge. Whereas I don't have
any … I needed somebody to sit down and explain it
to me very basically”. (participant 1-1)
Some felt that their doctors were ‘passionate’ and ‘had
good bedside manners’, but ‘were not informed’ about VP
and were unable to convey the seriousness of the situ-
ation. One woman who had IVF pregnancy commented
that ‘there was no plan’ and felt she was giving informa-
tion to her doctor:
I would have much preferred if the doctor told me
what the go was, not me handing information to him
and saying you should read this so you can save my
baby's life. Then [for] him [to] say to me ‘well when do
you want to have the baby?’… Well I don't know, I'm
not the doctor. I'm just this person who has tried myheart out to have a baby and I'm finally pregnant”.
(participant 1-4)
Most women talked about midwives being ‘fantastic’
but at the same time felt that most were uninformed
about VP and again did not realise the serious nature of
the condition. A number of women were uncertain
whether the midwives ‘understood the difference between
VP and placenta praevia’ and therefore would mistake
any vaginal bleeding for a placenta praevia and would
not take immediate action. This made a few women feel
that they would ‘not be taken seriously if they bled’:
“I was in a room of women who had low lying
placentas and placenta praevia. My biggest worry was
that if I rang the buzzer and said I'm having a bleed,
that I would not be treated correctly, because not every
midwife knew what was going on with me…”
(participant 1-2)
‘Coping with inconsistent information’
“It would make everything so much better if we could
have someone tell you what was going on. These are
the rules, this is what happens, this is what we do …
Whereas everything was all, “oh we'll just take it day
by day”. (participant 1-4)
Women continually reported receiving inconsistent in-
formation about VP, their own diagnosis and the best
management plan. There were also inconsistency in in-
formation including the timing of ultrasounds; safe dis-
tance to be away from the hospital; need for, and timing
of hospitalisation; fetal monitoring; and, timing of the
birth. Timing of birth was the area of most inconsistency
and confusion with more than 20 direct comments
about this issue. There were differences between clini-
cians within the same hospital, between hospitals, with
timing changed for individual women during pregnancy.
One woman clearly articulated her concerns:
“They said that I will have a CS at 39 weeks. My
obstetrician said “we can’t do it early”. She told me
that it was their procedure. I just don’t know whether
it is public hospital procedure or Australian
procedure. The first doctor told me it would be at
37 weeks and then this one told me it would be
39 weeks…then I don’t understand why they’ve given
me inconsistent information.” (participant 2-3)
Two women who had an elective CS planned for
38.5 weeks, talked about their concerns and worries of
having a late CS as they had found that the recom-
mended time for birth was 35-36 weeks on the internet.
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making for timing of birth, when she chose to have CS
at 35.5 weeks. She explained:
“He said ‘I'm leaving the decision in your hands,
when do you want to do the CS?’… I felt then that if
there was going to be something wrong with the baby
it was going to be all my fault because I was the one
who said “I want my CS done on this day”.
(participant 1-4)
Another woman spent a sleepless night before her
elective CS researching her decision on the internet as
she was concerned that the timing was not right:
“My doctor had, all through the pregnancy, discussed
going for 36 weeks but then because of my degree of
anxiety about it all, he said that he did further
research and decided he wanted to do it at 35 weeks. I
sort of switched back then and had a lot of
reservations about doing that because I was worried
about the effect of the baby being born that week
earlier. I was very upset in the end of having the baby
at 35 weeks. I think my doctor wanted the birth over
and done with and for somebody else to take care of
the baby”. (participant 1-1)
The internet also provided inconsistent information
about timing of the birth. For some women, the infor-
mation on the internet was different to what their doc-
tors provided. This inconsistency resulted in lack of
confidence and trust regarding their care and in the de-
cision making. One woman commented that “it's hard
because you don't know who to trust”. Another woman
said that “because of the inconsistency, it is making me
even more worried.”
In contrast, those women who received consistent in-
formation felt confident with one saying:
“I was quite confident in the way the doctors handled
things. They were quite reassuring and booked me in
at 36 weeks to have a caesarean. I did my own bit of
research with the International Vasa Praevia
Foundation. Their recommendation was 35 weeks not
36. So I did question that with my doctors and I was
quite reassured that the extra week was OK if I was
in hospital and if nothing had happened”.
(participant 1-2)
Women whose diagnosis was changed struggled even
more with the information and advice and mostly did
not trust their new diagnosis. Some woman in this group
despite being told that they did not have VP, didn’t get
enough reassurance and advice which added to theirlevel of uncertainty. Typical comments were: ‘they didn’t
tell me why I shouldn’t worry about it’ and ‘I didn’t feel
they were consistent’. One woman reported:
“The obstetrician said it’s not vasa praevia anymore
and that I could go home if I wanted. So we were very
confused. He couldn’t tell me … “well what is a safe
distance?” he couldn’t say…” (participant 2-2)
She consulted a VP group in the UK and an obstetrician
in another part of Australia and neither could say ‘what a
safe distance is’, so she decided to stay in hospital saying:
there didn't seem to be anything to guide us on that and
no-one really wanted to commit to saying anything. So
we don't know if we did the right thing or not. Of course I
didn't want to stay in hospital and that actually made it
worse because I had a daughter at home. I knew they
needed me at home. I was really torn whether or not I
was doing the right thing and then to be made to feel
that I was possibly taking up a bed and that I didn't
really need to be there and I didn't really have vasa
praevia, I was completely confused as to where I should
be”. (participant 2-2)
Women used the internet for information about vasa
praevia including the need for admission to hospital and
timing of birth. Women were either ‘encouraged to read on-
line’ or ‘advised to not go home and google’ by their doctors.
However, all women in this study used internet to get infor-
mation regarding VP. One woman said that her doctor en-
couraged her to read on the internet but then disregarded
the information and advice she found, for example:
“When he saw that I was quite worked up about it,
he was like “yeah, yeah, but don't believe everything
you read on the internet”. (participant 2-4)
Several women said that the stories on the internet were
‘horrible’, ‘frightening’, a ‘nightmare’ and about ‘people who
have lost babies’. But for at least five women, having
knowledge helped them process the experience and re-
duced their fears. Women felt like: ‘knowledge reduced my
fear’; and ‘I was not in in shock due to having the know-
ledge’; and, ‘I was less distressed because I knew about it’
and ‘not too shocked really because I knew it was a possi-
bility’. Some women said that reading those stories on
internet ‘helped me to know how lucky I am’; and ‘helped
me understand and know about different outcomes’.
‘Just a massive relief’ when it was all over
“It was just a massive relief… he was breathing fine …
we had this healthy little boy”. (participant 1-2)
Javid et al. BMC Pregnancy and Childbirth 2014, 14:318 Page 8 of 11
http://www.biomedcentral.com/1471-2393/14/318Ultimately relief came once the baby was safely born.
Nine of the 14 women expressed relief at hearing the
baby cry for the first time. Women made comments like:
‘she was out and that was all my concern. She was really
healthy’; ‘I could feel the tension melt away after she was
born safely’; ‘once she was out I was relieved - phew, it
was all over’ and ‘ once she was out I was phew … she's
not going to die now, she'll be fine’. Another said:
“I was just so relieved, all the tension and knowing
that everything went well and you could finally relax
and enjoy the baby.” (participant 2-4)
One woman clearly expressed this relief as:
“We were so incredibly in raptures in having her safe
that definitely the first six months it was just like
utopia. It was just so beautiful … we got her here. So
that joy bubble lasted a really long time. Almost like
an after effect that was also relaxing. Such euphoria in
having her safe”. (participant 2-5)
Some women felt relief during pregnancy when they
had a plan in place or when they were in hospital. One
woman ‘felt really safe’ during her admission in hospital
and considered herself ‘fortunate and lucky’. For
example:
“Once I was there in hospital I didn't really have a
concern that anything was going to go pear-shaped in
terms of losing the baby”. (participant 1-3)
‘Just a massive relief ’ when it was all over, describes
that most women were ‘desperate to get there and to
know that everything is going to be OK’. One woman
who was uncertain about her changed diagnosis de-
scribed her relief when she was told she would have an
emergency CS:
“When they said to us “it's going to come” we thought
“thank God it's going to be over, just get her out and
get her safe”. (participant 2-5)
This was in contrast to the woman who was diagnosed
during childbirth. She had ruptured membranes, vaginal
bleeding and emergency CS, but her baby died. She
described the time when she saw her baby for the first
time after being woken up from CS:
“They were ventilating him by hand. He looked pink,
so I couldn't believe that there was actually anything
really – I just couldn't reconcile in my mind that there
was something wrong… Then they told me that they
[doctors] had to revive him. They gave him two bloodtransfusions and he suffered a couple of heart attacks
on the table but that he was basically brain dead and
that there was little more that they could do for him”.
(participant 3-3)
‘Making the experience better’
The women in our study were reflective about their ex-
periences and thoughtful about what they would have
wanted for their care and what women in the future
would want. Many of these reflections included the is-
sues already discussed in the five themes above. Add-
itional issues included the importance of having a plan;
the need for support and someone to talk to and the
value of continuity of caregivers.
Many women felt isolated in their experience with few
of their friends understanding their experiences or even
the diagnosis. They would have valued someone to talk
to who understood what they were going through. Most
women commented that they preferred to talk to some-
body who was informed about VP. However, this was
not offered through the health system as one woman
commented:
“And at the hospital staff was really good. But I don't
know if they even knew about it. If they did, they
didn't say anything. But they were very nice at the
hospital. But yeah, I guess lack of information and
even being told if there was someone you could call or
talk to. That never even got offered. I think I found
that pretty hard”. (participant 2-4)
Continuity of care was also valued by women. One
woman said:
“… the one-on-one care. For me that was huge, being able
to have that constant one person who knew what was go-
ing on ……… someone that I trusted because I had had
her throughout my whole pregnancy… ” (participant 1-2)
Discussion
This is the first study undertaken to explore the experi-
ences of women with VP, either diagnosed during preg-
nancy or in childbirth. Our study included a spectrum of
women – some were diagnosed in pregnancy, others did
not have this confirmed as the pregnancy progressed
with a minority of women diagnosed in childbirth, in-
cluding one woman who experienced a neonatal death.
The main findings of the study were the lack of informa-
tion and certainty for women and the fear and anxiety
that this created.
Receiving consistent information is a challenge for
women with VP given the lack of guidelines and evi-
dence. There is still considerable uncertainty about the
optimal care of these women [26]. In many centres in
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nosis or even management once VP is confirmed and, an-
ecdotally, there seems to be limited consistency in
approach between obstetric specialists and/or centres.
Lack of knowledge and need for increasing awareness
about diagnosis and optimal management of VP have been
previously reported [27-29]. A survey of 128 obstetricians
in UK in 2006 showed that 59% of the obstetricians would
not offer hospitalisation and although 80% offered elective
CS for women diagnosed with VP, 46% would not perform
a CS until completed 38 weeks gestation [27].
Increasingly, consumers are accessing the internet for
health-related information. Several studies reveal that
people are using information from the internet to make
decisions regarding their health [30,31]. The internet as
a source of health information has been reported to “em-
power patients and increase their sense of control over
their disease” [32], but might also alter the clinician-
patient relationship. Our study shows that some women
used the internet as a source of current information for
VP and had uncertainty in who to trust: their care pro-
viders or the internet in relation to the best management
[33]. Some of the women in our study perceived that
they were more informed about their particular condi-
tion (VP) than their care providers. This struggle for the
‘right’ information sets up difficult dynamics for relation-
ship between the women and their clinicians.
The women in this study for whom the diagnosis was
not confirmed on a later ultrasound expressed additional
worries. In 2014, Rebrarber et al. reported the incidence
of VP was 1 in 1000 pregnancies. In this study authors
concluded that 24% of women diagnosed with VP during
the second trimester did not have confirmation of VP
across gestation. However, all women diagnosed in the
third trimester had confirmed diagnosis [18]. In our
study, women who were not confirmed to have VP still
reported considerable stress especially as there seemed
to be a lack of certainty and evidence about the “safe”
distance of the exposed vessels to the os. One woman in
our study who was diagnosed at 32 weeks had another
ultrasound at 36 weeks that did not confirm VP. How-
ever, VP was diagnosed at elective CS. It has been re-
ported in the literature that in late pregnancy there is a
possibility of poor visualisation of fetal vessels in the
ultrasound that may prevent a confirmation of VP
[14,22].
Other studies have shown how diagnosis ambiguity in
general creates stress. For example, a prospective study
of women who had prenatal diagnosis of fetal structural
anomaly by ultrasound reported that ambiguity regard-
ing diagnosis [34], as well as uncertainty about prenatal
outcome of the fetus to be associated with high psycho-
logical distress [35]. Another study showed that false
positive soft markers in prenatal ultrasound screeningprovoked maternal anxiety during pregnancy [36] and
reduced early mother-infant interaction at 2 months
after giving birth, although the infant was normal.
Many women in our study expressed fear, stress and
anxiety during their pregnancy and also felt lack of con-
trol in terms of decision-making. Several studies have fo-
cused on anxiety in pregnancy and have reported
antenatal anxiety [37-39] and worry [40] to be important
predictors of postnatal depression. For example, Lee at el.
2007 [37] reported increased association between ante-
natal anxiety and postnatal depression with the progres-
sion of pregnancy. It has also been shown that there is
strong association between postnatal depression and par-
enting stress [41].
It is possible that having considerable fear and anxiety
has effects on the pregnancy and the new mothering ex-
perience for the women. Some studies found that ante-
natal anxiety had negative effects on maternal-infant
attachment. Antenatal anxiety has also been shown to be
associated with difficult infant temperament [42] and
emotional and behavioural difficulties in childhood
[43-45]. This is a significant issue for the long-term
health of both mother and baby and needs to be ad-
dressed in future research and practice models.
The findings of this study demonstrate the need for in-
creased awareness of VP within sonographers, doctors
and midwives. A careful discussion is encouraged be-
tween the woman and her obstetrician so that the
woman understands her diagnosed condition, and her
management plan. Dissemination of current available in-
formation and establishment of the national guidelines
regarding accurate diagnosis and efficient management
will help to achieve optimal care.
We present a small qualitative study of a very rare
condition and the findings are presented from the per-
spective of these women. We did adhere to the guide-
lines for Qualitative research review guidelines (RATS)
which includes relevance of study question; appropriate-
ness of qualitative method; transparency of procedures;
and, soundness of interpretive approach [46]. As with all
qualitative studies based on individual recollections,
there is the potential for recall bias. There is also possi-
bility of selection bias as women who volunteered to be
interviewed might be different to those who did not al-
though this is a recognised limitation of qualitative stud-
ies, especially those of rare conditions. We recruited
women through an online foundation which may mean
that the findings are not generalizable to other women
with VP. However, internet access and usage in Australia
is high and many people (62%) use the internet for
health information and support [47]. There is a need for
larger study to confirm these findings. We did not inter-
view the clinicians involved in the care of these women
as the purpose of this study was to investigate women’s
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ever, their perceptions will be important to explore in
future research. In particular, the importance of consist-
ent information needs to be further explored with
clinicians.
Conclusion
Our study has shown that women with a diagnosis of VP,
even if it is subsequently not confirmed, have considerable
fears and anxieties related to their pregnancy and birth.
Women also found the lack of clear information regarding
VP added to their distress. Provision of clear evidence-
based information and sensitive support to women soon
after the initial diagnosis and throughout the pregnancy is
indicated to assist women and their families coping with
this serious but rare condition.
Further research needs to address the gaps in knowledge
regarding the diagnosis and management for women with
VP. The development of national or international guide-
lines may assist clinicians to provide high quality care for
women with this significant pregnancy complication.
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